시장보고서
상품코드
1193040

임상 리스크 분류 솔루션 시장 : 제품별, 도입별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

Clinical Risk Grouping Solutions Market By Product, By Deployment, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 290 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 임상 리스크 분류 솔루션 시장은 2021년에 4억 1500만 달러로 평가되며, 2031년에는 16억 3556만 달러에 달할 것으로 예측되고, 2022-2031년 14.6%의 CAGR을 기록하고 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장의 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 기회
  • COVID-19 영향 분석

제4장 임상 리스크 분류 솔루션 시장 : 제품별

  • 개요
    • 시장 규모 및 예측
  • 데이터 가시화 툴
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별 분석
    • 데이터 가시화 툴·임상 리스크 분류 솔루션 시장 : 유형별
      • 소프트웨어 시장 규모·예측 : 지역별
      • 서비스 시장 규모·예측 : 지역별
  • 데이터 애널리틱스
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 임상 리스크 분류 솔루션 시장 : 도입별

  • 개요
    • 시장 규모·예측
  • 프라이빗 클라우드
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별 분석
  • 퍼블릭 클라우드
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 하이브리드 클라우드
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 임상 리스크 분류 솔루션 시장 : 최종사용자별

  • 개요
    • 시장 규모·예측
  • 헬스케어 서비스 프로바이더
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 의료비 지불자
    • 주요 시장 동향, 성장요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 임상 리스크 분류 솔루션 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미의 시장 규모·예측 : 제품별
      • 북미의 데이터 가시화 툴·임상 리스크 분류 솔루션 시장 : 유형별
    • 북미 시장 규모·예측 : 도입별
    • 북미 시장 규모·예측 : 최종사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽의 시장 규모·예측 : 제품별
      • 유럽의 데이터 가시화 툴·임상 리스크 분류 솔루션 시장 : 유형별
    • 유럽 시장 규모·예측 : 도입별
    • 유럽 시장 규모·예측 : 최종사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 제품별
      • 아시아태평양의 데이터 가시화 툴·임상 리스크 분류 솔루션 시장 : 유형별
    • 아시아태평양의 시장 규모·예측 : 도입별
    • 아시아태평양의 시장 규모·예측 : 최종사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 호주
      • 인도
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 제품별
      • LAMEA의 데이터 가시화 툴·임상 리스크 분류 솔루션 시장 : 유형별
    • LAMEA의 시장 규모·예측 : 도입별
    • LAMEA의 시장 규모·예측 : 최종사용자별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카공화국
      • LAMEA의 기타 지역

제8장 기업 상황

  • 서론
  • 주요 성공 전략
  • 주요 10사의 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 발전

제9장 기업 개요

  • Conduent Inc
  • 3M Corporation
  • Optum, Inc
  • Cerner Corporation
  • Nuance Communications
  • Health Catalyst, Inc
  • HBI Solutions
  • Johns Hopkins University
  • Lightbeam Health Solutions
  • Dynamic Healthcare Systems
KSA 23.03.15

The global clinical risk grouping solutions market was valued at $415.0 million in 2021 and is projected to reach $1,635.56 million by 2031, registering a CAGR of 14.6% from 2022 to 2031.

The clinical risk grouping (CRG) solutions are a well-known system used for distinguishing and grouping individuals with the use of inpatient and ambulatory diagnosis and procedure codes, pharmaceutical records, and demographic data along with the functional health status to assign each individual to a specific risk group for future healthcare projections.

The growth of the clinical risk grouping solutions market is majorly driven by an alarming increase in the prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disease, and hypertension; a rise in the use of virtual health services, advancement in technologies of the healthcare sector, and surge in adoption of telehealth solution. In addition, the increase in focus of the healthcare industry on patient risk management and the rise in the adoption of advanced solutions for clinical risk grouping boosts the growth of the market.

In addition, the increase in physician workload, the need for an efficient solution due to the explosion in patient pool data created in the healthcare industry, and the widespread usage of big data solutions contribute to the growth of the market. Moreover, an increase in R&D activities in cloud storage technology and a rise in the number of healthcare IT service providers foster the clinical risk grouping solutions market. Moreover, the introduction of artificial intelligence (AI) in the development of various healthcare software boosts the growth of the market.

The clinical risk grouping solutions market is segmented on the basis of product, deployment model, end user, and region. By product, the segment market is classified into data visualization tools and data analytics. The data visualization tools are further divided into software, and services.

Depending on the deployment model, it is classified into private cloud, public cloud, and hybrid cloud. Based on the end-user market is categorized into healthcare service providers and healthcare payers. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Cerner corporation, Microsoft corporation, Alibaba Group Holding Limited, IBM, Dundas Data Visualization, Inc, SAS, Klipfolio, Oracle Inc., Domo, Inc., Koch Industries, Qlik Technologies, Salesforce, SAP, Sisense, TIBCO, and Greenway.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical risk grouping solutions market analysis from 2021 to 2031 to identify the prevailing clinical risk grouping solutions market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the clinical risk grouping solutions market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global clinical risk grouping solutions market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Data Visualization Tools
    • Type
    • Software
    • services
  • Data Analytics

By Deployment

  • Private Cloud
  • Public Cloud
  • Hybrid Cloud

By End User

  • Healthcare service providers
  • Helthcare payers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Conduent Inc
    • 3M Corporation
    • Optum, Inc
    • Cerner Corporation
    • Nuance Communications
    • Health Catalyst, Inc
    • HBI Solutions
    • Johns Hopkins University
    • Lightbeam Health Solutions
    • Dynamic Healthcare Systems

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Data Visualization Tools
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
      • 4.2.4.1 Software Market size and forecast, by region
      • 4.2.4.2 services Market size and forecast, by region
  • 4.3 Data Analytics
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Private Cloud
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Public Cloud
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Hybrid Cloud
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Healthcare service providers
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Helthcare payers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
      • 7.2.2.1 North America Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.2.3 North America Market size and forecast, by Deployment
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Deployment
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Deployment
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Deployment
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
      • 7.3.2.1 Europe Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.3.3 Europe Market size and forecast, by Deployment
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Deployment
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Deployment
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Deployment
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Deployment
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Product
      • 7.3.5.5.2 Market size and forecast, by Deployment
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product
      • 7.3.5.6.2 Market size and forecast, by Deployment
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
      • 7.4.2.1 Asia-Pacific Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Deployment
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Deployment
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Deployment
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Deployment
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Deployment
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Deployment
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
      • 7.5.2.1 LAMEA Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.5.3 LAMEA Market size and forecast, by Deployment
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Deployment
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Deployment
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Deployment
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Deployment
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Conduent Inc
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 3M Corporation
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Optum, Inc
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Cerner Corporation
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Nuance Communications
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Health Catalyst, Inc
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 HBI Solutions
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Johns Hopkins University
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Lightbeam Health Solutions
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Dynamic Healthcare Systems
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제